David Marín

The University of Texas MD Anderson Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 18 papers. Top paper: “Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors”.

Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

New England Journal of Medicine(2020)10.1056/nejmoa1910607

N/A

5.4DataRank · unranked

2164 citations

David Marín, Pinaki P. Banerjee, Homer A. Macapinlac, Philip A. Thompson, Rafet Başar +22 more

Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial

Nature Medicine(2024)10.1038/s41591-023-02785-8

N/A

4.0DataRank · unranked

468 citations

Ye Li, Rafet Başar, Hind Rafei, May Daher, Jinzhuang Dou +31 more

Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia

Blood(2021)10.1182/blood.2021013290

N/A

2.6DataRank · unranked

87 citations

Pinaki P. Banerjee, Denái R. Milton, Xianli Jiang, Christina Ganesh, Sajad Khazal +24 more

Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation

Journal of Clinical Oncology(2021)10.1200/jco.20.02608

N/A

2.1DataRank · unranked

66 citations

Ruitao Lin, David Marín, Hind Rafei, Mustafa Bdiwi, Peter F. Thall +38 more

Significance of minimal residual disease monitoring by real‐time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes

Cancer(2020)10.1002/cncr.32769

N/A

1.2DataRank · unranked

34 citations

Keyur P. Patel, Qaiser Bashir, David Marín, Sairah Ahmed, Amin M. Alousi +8 more

Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells

Blood(2021)10.1182/blood.2020007748

N/A

0.848DataRank · unranked

284 citations

Rafet Basar, Elif Gokdemir, Natalia Baran, Nadima Uprety, Ana Karen Nunez Cortes +56 more

CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0096

N/A

0.609DataRank · unranked

57 citations

Rafet Başar, May Daher, Hind Rafei, Ping Li, Nadima Uprety +42 more

Enhanced Recovery Stem-Cell Transplantation: Multidisciplinary Efforts to Improve Outcomes in Older Adults Undergoing Hematopoietic Stem-Cell Transplant

JCO Oncology Practice(2023)10.1200/op.22.00520

N/A

0.345DataRank · unranked

9 citations

Rachel Ombres, Rima M. Saliba, Nicholas Szewczyk, Latoya Adekoya, Tacara Soones +18 more

CD70-Targeting CAR NK Cells Overcome BCMA Downregulation and Improve Survival in High-risk Multiple Myeloma Models

Blood Cancer Discovery(2025)10.1158/2643-3230.bcd-25-0130

N/A

0.279DataRank · unranked

5 citations

Sunil Acharya, Francia Reyes-Silva, Rafet Başar, Nadima Uprety, Luz Yurany Moreno Rueda +24 more

CIS checkpoint deletion enhances the fitness of cord blood derived natural killer cells transduced with a chimeric antigen receptor

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.29.014472

N/A

0.224DataRank · unranked

2 citations

Rafet Basar, Elif Gokdemir, Natalia Baran, Nadima Uprety, Ana Karen Nunez Cortes +55 more

Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplant

Bone Marrow Transplantation(2023)10.1038/s41409-023-02006-3

N/A

0DataRank · unranked

9 citations

Yingjun Wang, Denái R. Milton, Zijun Y. Xu‐Monette, Elias Jabbour, May Daher +13 more

Nine-Year Follow-up of Patients with Relapsed Follicular Lymphoma after Nonmyeloablative Allogeneic Stem Cell Transplant and Autologous Transplant

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1377

N/A

0DataRank · unranked

7 citations

Denái R. Milton, Alison Gulbis, Elias Jabbour, Loretta J. Nastoupil, Celina Ledesma +16 more

Novel Clinical Trial Designs with Dose Optimization to Improve Long-term Outcomes

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2222

N/A

0DataRank · unranked

8 citations

Yong Zang, Andrew Chapple, Ying Yuan, Ruitao Lin, David Marín +2 more

Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering

Science Advances(2023)10.1126/sciadv.add6997

N/A

0DataRank · unranked

107 citations

Vakul Mohanty, Jinzhuang Dou, Yuefan Huang, Pinaki P. Banerjee, Qi Miao +25 more

Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells

Journal of Clinical Investigation(2021)10.1172/jci142116

N/A

0DataRank · unranked

254 citations

Mayra Shanley, Rafet Başar, May Daher, Joy Gumin, Daniel B. Zamler +45 more

Safety and long‐term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single‐center phase 1,2 trial

American Journal of Hematology(2024)10.1002/ajh.27254

N/A

0DataRank · unranked

5 citations

Kamal Alzahrani, Hagop M. Kantarjian, Denái R. Milton, Alison Gulbis, Koji Sasaki +18 more

CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells

Nature(2025)10.1038/s41586-025-09087-8

N/A

0DataRank · unranked

48 citations

Rafet Başar, Sunil Acharya, Yu-Sung Hsu, Pinghua Liu, Deqiang Zhang +53 more

Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapy

Cell Reports(2021)10.1016/j.celrep.2021.109432

N/A

0DataRank · unranked

34 citations

Nadima Uprety, Emily L. Ensley, May Daher, Kimberly Klein, Fernando D. Martínez +29 more